Published in Cancer Treat Rep on December 01, 1978
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol (1999) 17.43
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol (1996) 9.68
Pain and its treatment in outpatients with metastatic cancer. N Engl J Med (1994) 9.54
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol (1989) 5.44
High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol (2000) 4.60
Burnout syndrome in the practice of oncology: results of a random survey of 1,000 oncologists. J Clin Oncol (1991) 4.22
Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer (1993) 3.69
Dose: a critical factor in cancer chemotherapy. Am J Med (1980) 2.82
Adriamycin. A new anticancer drug with significant clinical activity. Ann Intern Med (1974) 2.77
Fast-neutron therapy in advanced head and neck cancer: a collaborative international randomized trial. Int J Radiat Oncol Biol Phys (1995) 2.64
Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. Int J Radiat Oncol Biol Phys (1992) 2.61
DTIC (NSC-45388) in malignant melanoma: a perspective. Cancer Treat Rep (1976) 2.59
A clinical review of bleomycin--a new antineoplastic agent. Cancer (1973) 2.53
Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys (1993) 2.42
Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med (1990) 2.32
Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol (1993) 2.28
Implantable central venous access system. Am J Surg (1984) 2.23
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804. Ann Oncol (2007) 2.17
Cancer of the breast: the past decade (first of two parts). N Engl J Med (1980) 2.14
Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome. Ann Intern Med (1984) 2.10
The integration of chemotherapy into a combined modality approach for cancer treatment. VI. Pancreatic adenocarcinoma. Cancer Treat Rev (1975) 2.10
Selection bias in trials of transplantation for metastatic breast cancer: have we picked the apple before it was ripe? J Clin Oncol (1997) 2.02
Second malignancies complicating Hodgkin's disease in remission. Lancet (1975) 1.90
Radioactive labeling of antibody: a simple and efficient method. Science (1983) 1.83
Complications and management of implanted venous access catheters. J Clin Oncol (1985) 1.82
Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy. J Neurosurg (1990) 1.76
Femoral vessel depth and the implications for groin node radiation. Int J Radiat Oncol Biol Phys (1993) 1.75
Carcinoembryonic antigen: clinical correlation with chemotherapy for metastatic gastrointestinal cancer. Cancer (1974) 1.74
Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am (2006) 1.70
Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis. J Clin Oncol (1995) 1.67
Combination versus single agent chemotherapy: a review of the basis for selection of drug treatment of cancer. Cancer (1975) 1.66
American Burkitt's lymphoma: a clinicopathologic study of 30 cases. II. Pathologic correlations. Am J Med (1975) 1.65
Neonatal megaloblastic anemia due to inherited transcobalamin II deficiency in two siblings. N Engl J Med (1971) 1.65
The pulmonary toxicity of antineoplastic agents. Semin Oncol (1982) 1.65
Depletion of glutathione in normal and malignant human cells in vivo by buthionine sulfoximine: clinical and biochemical results. J Natl Cancer Inst (1992) 1.61
A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B. J Clin Oncol (1989) 1.56
Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy. N Engl J Med (1978) 1.52
The cellular biology of the Reed-Sternberg cell. Blood (1994) 1.50
Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet (1975) 1.49
Transferrin receptor expression in nonsmall cell lung cancer. Histopathologic and clinical correlates. Cancer (1995) 1.49
Fast neutron radiation for recurrent pleomorphic adenomas of the parotid gland. Am J Clin Oncol (1992) 1.49
Socioeconomic status and cancer survival. J Clin Oncol (1991) 1.48
Radiation Therapy Oncology Group (RTOG) survival data on anaplastic astrocytomas of the brain: does a more aggressive form of treatment adversely impact survival? Int J Radiat Oncol Biol Phys (1989) 1.47
Training the radiation oncologist for the twenty-first century. Int J Radiat Oncol Biol Phys (1996) 1.47
A randomized prospective trial of radiation therapy for AIDS-associated Kaposi's sarcoma. Int J Radiat Oncol Biol Phys (1993) 1.46
A decade of combination chemotherapy of advanced Hodgkin's disease. Cancer (1972) 1.46
Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). J Clin Oncol (1983) 1.45
Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone. Ann Intern Med (1972) 1.44
Who should pay for clinical research? J Clin Oncol (1990) 1.41
Hypercalcemia in malignant lymphoma and leukemia. Ann N Y Acad Sci (1974) 1.40
Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy. N Engl J Med (1972) 1.40
Fast neutron radiotherapy for locally advanced prostate cancer: results of an RTOG randomized study. Int J Radiat Oncol Biol Phys (1985) 1.38
Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation. Cancer J Sci Am (2006) 1.38
Acute-phase proteins or tumour markers: the role of SAA, SAP, CRP and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases. Scand J Immunol (1984) 1.38
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med (1980) 1.37
Philadelphia-chromosome-positive preleukaemic state. Lancet (1972) 1.33
The kinetics of 67gallium incorporation into inflammatory lesions: experimental and clinical studies. J Lab Clin Med (1974) 1.33
Combination chemotherapy for advanced breast cancer: response and effect on survival. Ann Intern Med (1976) 1.33
L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease. N Engl J Med (1969) 1.29
Cost effective Internet access and video conferencing for a community cancer network. Proc Annu Symp Comput Appl Med Care (1995) 1.28
Cyclical combination chemotherapy for advanced breast carcinoma. Br Med J (1974) 1.26
Clinical implications of cytogenetic variants in chronic myelocytic leukemia (CML). Blood (1968) 1.26
Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group. J Clin Oncol (1989) 1.25
Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council. Int J Radiat Oncol Biol Phys (1993) 1.25
Cancer of the breast: the past decade (second of two parts). N Engl J Med (1980) 1.24
l-asparaginase resistance in human leukemia--asparagine synthetase. Biochem Pharmacol (1969) 1.23
Sequential nonsurgical and surgical staging of non-Hodgkin's lymphoma. Ann Intern Med (1976) 1.22
Microangiopathic hemolytic anemia and cancer: a review. Medicine (Baltimore) (1979) 1.21
A randomized multicenter study of remifentanil compared with halothane in neonates and infants undergoing pyloromyotomy. I. Emergence and recovery profiles. Anesth Analg (2001) 1.19
Multimodality therapy for malignant mesothelioma based on a study of natural history. Am J Med (1980) 1.19
American Burkitt's lymphoma: a clinicopathologic study of 30 cases. I. Clinical factors relating to prolonged survival. Am J Med (1975) 1.15
Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with L-phenylalanine mustard. Cancer (1976) 1.14
Hematologic and cytogenetic remission of blastic transformation in chronic granulocytic leukemia. Blood (1971) 1.14
Characterization of a human malignant mesothelioma cell line (H-MESO-1): a biphasic solid and ascitic tumor model. Cancer Res (1987) 1.14
Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid. Cancer Res (1991) 1.13
Recent advances in the treatment of advanced colorectal cancer. Cancer (1993) 1.12
Risk of new cancers in patients with Hodgkin's disease. Cancer (1977) 1.11
Characteristics of blast crisis in chronic granulocytic leukemia. Blood (1977) 1.09
A review of chemotherapy in gastric cancer. Cancer (1974) 1.09
Hypercalcemia in chronic granulocytic leukemia. Cancer (1971) 1.08
Nephrosis of Hodgkin disease. An immune complex-induced lesion. Arch Intern Med (1973) 1.08
Biliary tract obstruction secondary to cancer: management guidelines and selected literature review. J Clin Oncol (1987) 1.08
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study. J Clin Oncol (1996) 1.07
Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer. J Clin Oncol (1996) 1.07
The implementation of telemedicine within a community cancer network. J Am Med Inform Assoc (1997) 1.07
Reduction of radioactive seed embolization to the lung following prostate brachytherapy. Int J Radiat Oncol Biol Phys (1998) 1.06
Combined 5-fluorouracil and irradiation for transitional cell carcinoma of the urinary bladder. Int J Radiat Oncol Biol Phys (1990) 1.06
Fast neutron radiotherapy: where have we been and where are we going? The jury is still out--regarding Maor et al., IJROBP 32:599-604; 1995. Int J Radiat Oncol Biol Phys (1995) 1.06
Histologic progression in non-Hodgkin's lymphoma. Blood (1982) 1.06
Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD. Ann Intern Med (1986) 1.06
Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy. Cancer (1983) 1.05
Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients. Cancer Res (1979) 1.05
Carcinocythemia (carcinoma cell leukemia). Report of two cases with English literature review. Cancer (1984) 1.05
Neutron radiotherapy for adenoid cystic carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg (1993) 1.05
Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group B. Ann Oncol (1998) 1.04
Treatment and surgical staging of testicular and primary extragonadal germ cell cancer. JAMA (1983) 1.04
Eight years experience with neutron radiotherapy in the treatment of stages C and D prostate cancer: updated results of the RTOG 7704 randomized clinical trial. Prostate (1987) 1.04
Stereotactic radiosurgery: a review and comparison of methods. J Clin Oncol (1994) 1.04